| |
|
|
|
AC Immune SA  
|
|
7.13 0.27 (0.04%) |
07-14 16:00 |
|
Open: |
6.82 |
Pre close: |
6.86 |
Target:
|
8.74 
|
|
High: |
7.2 |
Low: |
6.82 |
Resistance:
|
7.48
8.74
|
|
Volume: |
49,852 |
Market Cap: |
512M |
Support:
|
6.90
6.54
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.10
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
6.99 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
6.96 |
Stochastic Oscillator |
%K(14,3):
|
47.52 |
|
MA(250): |
6.84 |
%D(3): |
58.98 |
|
Average Volume(K) |
3-Month: |
8250
|
52-Week |
High:
|
10.14 |
|
10-Days: |
5834 |
Low: |
4.07 |
|
RSI |
RSI(14):
|
49.46 |
Change(%): |
19.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
-10.2 |
Shares Out. (M) |
71.86 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
-4.8 |
Shares Float (M) |
26.86 |
|
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
47.90 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
-83.5 |
% Held by Institutions |
26.78 |
|
Forward EPS |
-0.837 |
Gross Profit (p.s.) |
0.843 |
Shares Short (K) |
616 |
|
Book Value (p.s.) |
2.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-12.75 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.34 |
|
Profit Margin |
-53.36 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
